Compound Rh2 (Anticancer agent 133) is a cytotoxic and antimetastatic agent that induces cell cycle arrest, apoptosis, and autophagy. Additionally, it suppresses cell metastasis through the inhibition of EGFR expression, which is mediated by FAK-regulated integrin beta1 [1].
Molecular Weight:
602.71
Formula:
C24H19Cl3N5ORh
Target:
EGFR|||Autophagy|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
